Literature DB >> 27046161

2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Donald M Lloyd-Jones, Pamela B Morris, Christie M Ballantyne, Kim K Birtcher, David D Daly, Sondra M DePalma, Margo B Minissian, Carl E Orringer, Sidney C Smith.   

Abstract

Entities:  

Keywords:  ACC Expert Consensus Decision Pathway; ASCVD; LDL-C; PCSK9 inhibitors; bile acid sequestrants; cholesterol; dyslipidemia; ezetimibe; lipids; statins

Mesh：

Substances：

Year:  2016        PMID： 27046161     DOI： 10.1016/j.jacc.2016.03.519

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  99 in total

Review 1.  Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Its Inhibitors: a Review of Physiology, Biology, and Clinical Data.

Authors:  Ashwin Durairaj; Alberto Sabates; Jonathan Nieves; Brian Moraes; Seth Baum
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

Review 2.  Low Density Lipoprotein (LDL) Cholesterol as a Causal Role for Atherosclerotic Disease: Potential Role of PCSK9 Inhibitors.

Authors:  Rita Del Pinto; Davide Grassi; Giuliana Properzi; Giovambattista Desideri; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-06-24

3.  In Reply.

Authors:  Klaus G Parhofer
Journal:  Dtsch Arztebl Int       Date:  2016-09-23       Impact factor: 5.594

4.  Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.

Authors:  Sheldon W Tobe; James A Stone; Todd Anderson; Simon Bacon; Alice Y Y Cheng; Stella S Daskalopoulou; Justin A Ezekowitz; Jean C Gregoire; Gord Gubitz; Rahul Jain; Karim Keshavjee; Patty Lindsay; Mary L'Abbe; David C W Lau; Lawrence A Leiter; Eileen O'Meara; Glen J Pearson; Doreen M Rabi; Diana Sherifali; Peter Selby; Jack V Tu; Sean Wharton; Kimberly M Walker; Diane Hua-Stewart; Peter P Liu
Journal:  CMAJ       Date:  2018-10-09       Impact factor: 8.262

Review 5.  Genetics of Dyslipidemia and Ischemic Heart Disease.

Authors:  Kavita Sharma; Ragavendra R Baliga
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 6.  Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations.

Authors:  Bhavin B Adhyaru; Terry A Jacobson
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

7.  Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.

Authors:  Radmila Lyubarova; Jennifer G Robinson; Michael Miller; Debra L Simmons; Ping Xu; Beth L Abramson; Marshall B Elam; Todd M Brown; Ruth McBride; Jerome L Fleg; Patrice Desvigne-Nickens; Woubeshet Ayenew; William E Boden
Journal:  J Clin Lipidol       Date:  2017-07-05       Impact factor: 4.766

8.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

9.  The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.

Authors:  Tracey G Simon; Kathleen E Corey; Christopher P Cannon; Michael Blazing; Jeong-Gun Park; Michelle L O'Donoghue; Raymond T Chung; Robert P Giugliano
Journal:  Int J Cardiol       Date:  2018-05-26       Impact factor: 4.164

10.  Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.

Authors:  Robert P Giugliano; Anthony Keech; Sabina A Murphy; Kurt Huber; S Lale Tokgozoglu; Basil S Lewis; Jorge Ferreira; Armando Lira Pineda; Ransi Somaratne; Peter S Sever; Terje R Pedersen; Marc S Sabatine
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.